Abstract
Objectives
To assess the efficacy and safety of 10-d sequential therapy compared to 5 to 14-d triple therapy for treating Helicobacter pylori infections in children according to the eradication rates.
Methods
The Cochrane Library, MEDLINE, EMBASE, China National Knowledge Infrastructure databases, and other sources were searched in November 2014 without language restrictions. Randomized controlled trials (RCTs) that compared sequential therapy with triple therapy for H. pylori eradication in children were included. Dichotomous data were pooled to obtain the relative risk (RR) of the eradication rate with a 95 % confidence interval (CI).
Results
Fourteen RCTs with 1698 participants (718 and 980 for sequential and triple therapy, respectively) were included. The intention-to-treat eradication rates were 73 % (95 % CI: 70–76) and 66 % (95 % CI: 64–70) for sequential and triple therapy, respectively. The pooled RR was 1.16 (95 % CI: 1.09–1.23), resulting in a number needed to treat of 16 (95 % CI: 10–48), favoring sequential therapy. Sequential therapy was superior to 7- and 10-d triple therapy. Sequential and triple therapy did not differ significantly in the overall risk of adverse effects.
Conclusions
In children, sequential therapy appears to be superior to triple therapy for H. pylori eradication, although the eradication rates remain lower than the expected goal with both treatments. Factors-associated with a higher risk of eradication failure, such as compliance and antimicrobial resistance, remain insufficiently investigated. Therefore, further high-quality RCTs are needed to compare these different eradication treatment approaches.
Similar content being viewed by others
References
Seo JH, Woo HO, Youn HS, Rhee KH. Antibiotics resistance of Helicobacter pylori and treatment modalities in children with infection. Korean J Pediatr. 2014;57:67–71.
Pacifico L, Osborn JF, Tromba V, Romaggioli S, Bascetta S, Chiesa C. Helicobacter pylori infection and extragastric disorders in children: a critical update. World J Gastroenterol. 2014;20:1379–401.
Huang FC, Chang MH, Hsu HY, Lee PI, Shun CT. Long-term follow-up of duodenal ulcer in children before and after eradication of Helicobacter pylori. J Pediatr Gastroenterol Nutr. 1999;28:76–80.
Tam YH, Lee KH, To KF, Lee PI, Shun CT. Helicobacter pylori-positive versus Helicobacter pylori-negative idiopathic peptic ulcers in children with their long-term outcomes. J Pediatr Gastroenterol Nutr. 2009;48:299–305.
Koletzko S, Jones NL, Goodman KJ, et al; H pylori working groups of ESPGHAN and NASPGHAN. Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children. J Pediatr Gastroenterol Nutr. 2011;53:230–43.
Oderda G, Shcherbakov P, Bontems P, et al; European Pediatric Task Force on Helicobacter pylori. Results from the Pediatric European Register for Treatment of Helicobacter pylori (PERTH). Helicobacter. 2007;12:150–6.
Zullo A, Rinaldi V, Winn S, et al. A new highly effective short-term therapy schedule for Helicobacter pylori eradication. Aliment Pharmacol Ther. 2000;14:715–8.
Gatta L, Vakil N, Leandro G, Di Mario F, Vaira D. Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children. Am J Gastroenterol. 2009;12:3069–79.
Horvath A, Dziechciarz P, Szajewska H. Meta-analysis: sequential therapy for Helicobacter pylori eradication in children. Aliment Pharmacol Ther. 2012;36:534–41.
Horvath A, Dziechciarz P, Szajewska H. Letter: sequential therapy for Helicobacter pylori eradication in children’ updated meta-analysis of randomized controlled trials. Aliment Pharmacol Ther. 2013;37:835–6.
Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.0.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available at: http://www.cochrane-handbook.org.
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
Higgins JPT, Altman DG; On behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Assessing risk of bias in included studies. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions. Chichester, UK: Wiley-Blackwell; 2008. p. 187–241.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.
Francavilla R, Lionetti E, Castellaneta SP, et al. Improved efficacy of 10-day sequential treatment for Helicobacter pylori eradication in children: a randomized trial. Gastroenterology. 2005;129:1414–9.
Lerro P, Kuvidi M, Baldi M, Calvo PL, Barbera C. A 10-day sequential therapy: new option for Helicobacter pylori eradication in children. Dig Liver Dis. 2006;38:A104–5.
Hurduc V, Dragomir D, Leseanu G, et al. Comparison of sequential and triple therapies in the eradication of H. pylori infection in symptomatic children. Gut. 2007;56:A243.
Lu JH, Xu MY, Sheng Y, Yang WX. Comparison of the efficacy of 10-day sequential therapy and conventional triple therapy for Helicobacter pylori eradication in children. Zhongguo Dang Dai Er Ke Za Zhi. 2010;12:988–90.
Baysoy G, Saltik Temizel I, Uslu N, et al. Sequential therapy is not effective for the treatment of Helicobacter pylori infection in children. J Pediatr Gastroenterol Nutr. 2010;50:E131.
Bontems P, Kalach N, Oderda G, et al. Sequential therapy versus tailored triple therapies for Helicobacter pylori infection in children. J Pediatr Gastroenterol Nutr. 2011;53:646–50.
Anania C, Di Nardo G, Olivero G, Ferraro F, Olivero E, Pacifico L. Sequential versus concomitant therapy for Helicobacter pylori infection in children: a pilot study. J Pediatr Gastroenterol Nutr. 2011;52:E170–1.
Albrecht P, Kotowska M, Szajewska H. Sequential therapy compared with standard triple therapy for Helicobacter pylori eradication in children: a double-blind, randomized, controlled trial. J Pediatr. 2011;159:45–9.
Liu LF, Zhen LN, Zhao Y, et al. The efficacy of sequential therapy and standard triple therapy for eradication of Helicobacter pylori infection in children. J Clin Pediatr. 2011;29:925–8.
Huang J, Gong ST, Qu WJ, et al. A 10 day sequential therapy for eradication of Helicobacter pylori infection in children. Zhongghua Er Ke Za Zhi. 2012;50:563–7.
Huang J, Zhou L, Geng L, et al. Randomised controlled trial: sequential vs. standard triple therapy for Helicobacter pylori infection in Chinese children-a multicentre, open-labelled study. Aliment Pharmacol Ther. 2013;38:1230–5.
Laving A, Kamenwa R, Sayed S, Kimang’a AN, Revathi G. Effectiveness of sequential v. standard triple therapy for the treatment of Helicobacter pylori infection in children in Nairobi, Kenya. S Afr Med J. 2013;103:921–4.
Baysoy G, Saltik Temizel IN, Uslu N, et al. Ornidazole-based sequential therapy is not effective in Helicobacter pylori eradication in children. Turk J Gastroenterol. 2013;24:382–6.
Kutluk G, Tutar E, Bayrak A, et al. Sequential therapy versus standard triple therapy for Helicobacter pylori eradication in children: any advantage in clarithromycin-resistant strains? Eur J Gastroenterol Hepatol. 2014;26:1202–8.
Sterne JA, Egger M, Smith GD. Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ. 2001;323:101–5.
Graham DY, Lu H, Yamaoka Y. A report card to grade Helicobacter pylori therapy. Helicobacter. 2007;12:275–8.
Vakil N, Megraud F. Eradication treament for Helicobacter pylori. Gastroenterology. 2007;133:985–1001.
Conflict of Interest
None.
Source of Funding
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Huang, Y., Zhan, X. Sequential Therapy is Superior to Triple Therapy for Helicobacter pylori Infection in Children: A Meta-Analysis. Indian J Pediatr 83, 307–315 (2016). https://doi.org/10.1007/s12098-015-1878-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-015-1878-0